Real-time enrollment status for this glioma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:08 PM UTC
| NCT Number | NCT05345002 |
| Recruiting Status | Recruiting |
| Condition | Glioma |
| Phase | PHASE2 |
| Target Enrollment | 55 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stephen Bagley, MD, MSCE |
| Last Updated on CT.gov | February 20, 2026 (Feb 20, 2026) |
As of July 16, 2026: Clinical trial NCT05345002 is currently recruiting participants. This phase2 study for glioma is actively seeking new participants at 1 location across the United States. The study is sponsored by Stephen Bagley, MD, MSCE. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05345002 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05345002 was last updated Feb 20, 2026 (February 20, 2026). HelloStudys verifies this status automatically.